Skip to content
Trial Eligibility
Menu

CPAP for the Treatment of Supine Hypertension

NCT05489575

This study is recruiting at 1 US site in 1 state, according to its ClinicalTrials.gov record last updated .

Summary

This study aims to learn about the effects of continuous positive airway pressure (CPAP) on people with autonomic failure and high blood pressure when lying down (supine hypertension) to determine if it can be used to treat their high blood pressure during the night. CPAP (a widely used treatment for sleep apnea) involves using a machine that blows air into a tube connected to a mask covering the nose, or nose and mouth, to apply a low air pressure in the airways.

Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov

Conditions studied

  • Autonomic Failure
  • Pure Autonomic Failure
  • Multiple System Atrophy
  • Parkinson Disease
  • Supine Hypertension
  • Neurogenic Orthostatic Hypotension

Eligibility basics and study details

Study type
Interventional
Phase
Not applicable
Ages
40 to 80 years
Sex
All
Healthy volunteers
Not accepted
Sponsor
Vanderbilt University Medical Center
Last updated on ClinicalTrials.gov
April 7, 2026

These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.

US recruiting sites

Tennessee · 1

  • Autonomic Dysfunction Center/ Vanderbilt University Medical Center · Nashville, TN

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.